Numerai’s NeoGenomics NEO Stock Holding History

Numerai’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-64,783	Closed	-$474K	–	625
2025 Q2	$474K	Buy	+64,783	New	+$523K	0.07%	291

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Numerai's NEO Position: Q3 2025 in Review

Numerai sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 64,783 shares — an estimated $474K sold.

Numerai first reported a position in NEO in Q2 2025 and held it in 1 quarter. The position peaked at $474K in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

Numerai reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
Numerai sold 64,783 NeoGenomics shares in Q3 2025, an estimated $474K.
Numerai first reported a position in NeoGenomics in Q2 2025 and held it in 1 quarter.
Numerai's NeoGenomics position peaked at $474K in Q2 2025.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Numerai's 13F filing for Q3 2025, filed 14 Nov 2025.